Overturning a ruling from a district court judge, the U.S. Court of Appeals for the Federal Circuit Wednesday invalidated two patents protecting Mississauga, Ontario-based Nuvo Pharmaceuticals Inc.'s Vimovo (naproxen/esomeprazole magnesium), clearing the way for generics of the gastric-friendly nonsteroidal inflammatory drug.